These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3322442)

  • 41. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
    Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
    J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polycythemia Vera.
    Spivak JL
    Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anagrelide: a review of its use in the management of essential thrombocythaemia.
    Wagstaff AJ; Keating GM
    Drugs; 2006; 66(1):111-31. PubMed ID: 16398570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marrow cellularity in the diagnosis of polycythaemia.
    Lucie NP; Young GA
    J Clin Pathol; 1983 Feb; 36(2):180-3. PubMed ID: 6826773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary thrombocythaemia: a composite approach to diagnosis.
    Messinezy M; Westwood N; Sawyer B; Grace R; Holland LJ; Lawrie AS; Pearson TC
    Clin Lab Haematol; 1994 Jun; 16(2):139-48. PubMed ID: 7955922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythropoietin measurements in the differential diagnosis of polycythaemia.
    Napier JA; Janowska-Wieczorek A
    Br J Haematol; 1981 Jul; 48(3):393-401. PubMed ID: 7259989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The classification and diagnosis of erythrocytosis.
    McMullin MF
    Int J Lab Hematol; 2008 Dec; 30(6):447-59. PubMed ID: 18823397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
    Campbell PJ; Scott LM; Buck G; Wheatley K; East CL; Marsden JT; Duffy A; Boyd EM; Bench AJ; Scott MA; Vassiliou GS; Milligan DW; Smith SR; Erber WN; Bareford D; Wilkins BS; Reilly JT; Harrison CN; Green AR; ; ;
    Lancet; 2005 Dec; 366(9501):1945-53. PubMed ID: 16325696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombosis and risk factors in female patients with a rare acquired thrombophilia: chronic myeloproliferative disorder - polycythaemia vera and essential thrombocythaemia.
    Pósfai É; Marton I; Kiss-László Z; Kotosz B; Széll M; Borbényi Z
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3810-8. PubMed ID: 25555871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral blood lymphocyte subpopulations in polycythaemia and thrombocythaemia.
    Eridani S; Fiorini GF; Batten E
    Scand J Haematol; 1983 May; 30(5):479-85. PubMed ID: 6222468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
    Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
    Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias.
    Westwood NB; Pearson TC
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():95-103. PubMed ID: 8951779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
    Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
    Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acquired mutation of JAK2 tyrosine kinase and polycythaemia vera].
    Pargade V; Darnige L; Gaussem P
    Ann Biol Clin (Paris); 2006; 64(1):3-9. PubMed ID: 16420986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombocytosis and thrombocythemia.
    Mitus AJ; Schafer AI
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):157-78. PubMed ID: 2155903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
    Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
    Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is obstructive sleep apnoea syndrome really one of the causes of secondary polycythaemia?
    Solmaz S; Duksal F; Ganidağlı S
    Hematology; 2015 Mar; 20(2):108-11. PubMed ID: 24801394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What clinical and laboratory data are indicative of polycythemia and when are blood volume studies needed?
    Ferrant A
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):151-4. PubMed ID: 8036131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Essential thrombocythaemia.
    Tobelem G
    Baillieres Clin Haematol; 1989 Jul; 2(3):719-28. PubMed ID: 2505875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.
    Randi ML; Bertozzi I; Cosi E; Santarossa C; Peroni E; Fabris F
    Ann Hematol; 2016 Jan; 95(2):233-7. PubMed ID: 26547864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.